|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
b8420938 |
| 003 |
CoU |
| 005 |
20160224163530.0 |
| 008 |
151027s2015 dcu b f000 0 eng c |
| 010 |
|
|
|a 2015461367
|
| 035 |
|
|
|a (OCoLC)ocn917503036
|
| 035 |
|
|
|a tmp97430683
|
| 040 |
|
|
|a GPO
|b eng
|e rda
|c GPO
|d DLC
|d OCLCO
|d GPO
|d MvI
|
| 042 |
|
|
|a pcc
|
| 043 |
|
|
|a n-us---
|
| 049 |
|
|
|a COD9
|
| 074 |
|
|
|a 1019-A-01
|
| 086 |
0 |
|
|a Y 4.C 73/8:113-137
|
| 086 |
0 |
|
|a Y 4.C 73/8:113-137
|
| 088 |
|
|
|a Serial no. 113-137 (United States. Congress. House. Committee on Energy and Commerce)
|
| 110 |
1 |
|
|a United States.
|b Congress.
|b House.
|b Committee on Energy and Commerce.
|b Subcommittee on Health,
|e author.
|0 http://id.loc.gov/authorities/names/no2001059548.
|
| 245 |
1 |
0 |
|a Improving predictability and transparency in DEA and FDA regulation :
|b hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 7, 2014.
|
| 264 |
|
1 |
|a Washington :
|b U.S. Government Publishing Office,
|c 2015.
|
| 264 |
|
2 |
|a Washington, DC :
|b For sale by the Superintendent of Documents, U.S. Government Publishing Office.
|
| 300 |
|
|
|a iv, 217 pages ;
|c 24 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent.
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia.
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier.
|
| 500 |
|
|
|a Shipping list number: 2015-0330-P.
|
| 504 |
|
|
|a Includes bibliographical references.
|
| 500 |
|
|
|a "Serial Number 113-147."
|
| 590 |
|
|
|3 Documents in PASCAL:
|a FIPNet Preservation copy of record in partnership with the US Government Publishing Office. Electronic version is available, email govpubs@colorado.edu for help locating a digital copy.
|
| 650 |
|
0 |
|a Drugs of abuse
|x Law and legislation
|z United States.
|
| 650 |
|
0 |
|a Drugs
|x Law and legislation
|z United States.
|0 http://id.loc.gov/authorities/subjects/sh2008102437.
|
| 650 |
|
0 |
|a Drug approval
|z United States.
|0 http://id.loc.gov/authorities/subjects/sh2009123884.
|
| 650 |
|
0 |
|a Drug accessibility
|z United States.
|
| 650 |
|
7 |
|a Drug accessibility.
|2 fast
|0 (OCoLC)fst01749120.
|
| 650 |
|
7 |
|a Drug approval.
|2 fast
|0 (OCoLC)fst00898661.
|
| 650 |
|
7 |
|a Drugs
|x Law and legislation.
|2 fast
|0 (OCoLC)fst00898830.
|
| 650 |
|
7 |
|a Drugs of abuse
|x Law and legislation.
|2 fast
|0 (OCoLC)fst00898984.
|
| 651 |
|
7 |
|a United States.
|2 fast
|0 (OCoLC)fst01204155.
|
| 655 |
|
7 |
|a Legislative hearings.
|2 fast
|0 (OCoLC)fst01910825.
|
| 655 |
|
7 |
|a Legislative hearings.
|2 lcgft
|0 http://id.loc.gov/authorities/genreForms/gf2013025047.
|
| 776 |
0 |
8 |
|i Online version:
|a United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.
|t Improving predictability and transparency in DEA and FDA regulation
|w (OCoLC)914355788.
|
| 776 |
0 |
8 |
|i Microfiche version:
|a United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.
|t Improving predictability and transparency in DEA and FDA regulation
|w (OCoLC)932070200.
|
| 907 |
|
|
|a .b84209380
|b 06-01-23
|c 09-01-15
|
| 998 |
|
|
|a pas
|b 09-01-15
|c -
|d m
|e -
|f eng
|g dcu
|h 0
|i 4
|
| 907 |
|
|
|a .b84209380
|b 07-21-17
|c 09-01-15
|
| 944 |
|
|
|a MARS - RDA ENRICHED
|
| 907 |
|
|
|a .b84209380
|b 12-02-16
|c 09-01-15
|
| 999 |
f |
f |
|i 3443a95c-113b-52ce-a660-4dc648e35b13
|s 3232d4fa-f935-5677-8c54-4f948d8ccb7a
|
| 952 |
f |
f |
|p Reading room
|a University of Colorado Boulder
|b Boulder Campus
|c Offsite
|d PASCAL Offsite - Use in Reading Room Only
|e Y 4.C 73/8:113-137
|h Superintendent of Documents classification
|i gov pres steward
|m P203070304052
|n 1
|
